Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib.
about
A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycinProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerProtein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingAnti-cancer activity of glucosamine through inhibition of N-linked glycosylationInhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development.Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysisFluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia.Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons.Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo.Targeting EGFR resistance networks in head and neck cancer.2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibitionN-glycosylation of the transient receptor potential melastatin 8 channel is altered in pancreatic cancer cells.A new look at the ALK gene in cancer: copy number gain and amplification.The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor.Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer.Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells.Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor Agents.ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling.Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.A premature termination of human epidermal growth factor receptor transcription in Escherichia coli.Influence of estrogen in non-small cell lung cancer and its clinical implications.Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.
P2860
Q24630256-1CDA1484-407E-46DD-9AB6-A918295BEEEDQ26852215-0D1AC387-6232-4BA1-9ED1-195DD9EAB913Q26861795-088F2865-22D4-451F-BFDF-05E642F250D5Q33755089-1F8CB041-B3EB-42F5-8695-ABFC5A7C06E8Q34109019-3A8C3711-D25D-434F-9651-912B2FABE9FCQ34727996-BE918FCC-C785-4B93-9B7D-BAD991F0D73EQ35958787-BDDBC341-3EDC-4C92-B2C3-A064C3809F5BQ36318153-81BF9102-FBA8-407E-B8F5-505EB504FAD2Q36320314-AB885A72-5BEB-4604-A389-6D3752A8F9D1Q36629452-916E30F8-7F3C-4C19-93AF-0818E7474232Q37405633-F06E723D-81C7-4718-8460-F7B941D56C18Q37616082-7E5CE7ED-F2B8-435C-894D-9E3EEF194D04Q37649220-4E1E3A9D-E673-4434-A1AC-78D5068E4D87Q38600727-9B23CD75-F3CA-4A27-82BF-FCEA60DE9E30Q38760747-4016C19B-9E10-4872-B57F-C6D29D371D77Q39031210-EBEC5C38-54AB-477D-BF55-12519A84844EQ39066320-82147BD7-8654-4B6F-9541-98D78013DBA5Q41366826-73C191C7-7E8A-4F44-983F-9580B3945683Q42177413-C2DD2B53-C246-4D30-8737-080E2148AD68Q47120271-379EBA1A-85E6-4D0D-9A82-E9E2CA553301Q47215827-B0CCBB34-34C5-4E2B-85A6-B16CF26C457DQ47988571-ED66200B-9127-4E40-BA5E-EFECA4CD10D1Q49805726-335C6CC8-16B2-4597-86BB-4DA2CDB1197FQ49981787-28B4D097-DE0B-48A8-98CD-87D7DB3F1B9BQ54278801-8EE5989A-1AB8-4E0F-927E-7E9FCCB842E9Q54981518-0623AE22-0998-4560-82E2-ECAE2202CC9EQ54985550-BBF3FFB1-7E44-43D4-984D-56FECE09C43B
P2860
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@en
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@nl
type
label
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@en
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@nl
prefLabel
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@en
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@nl
P2093
P2860
P1476
Activation of ER stress and in ...... ung cancer cells to erlotinib.
@en
P2093
Missak Haigentz
Roman Perez-Soler
Tianhong Li
Yi-He Ling
P2860
P2888
P304
P356
10.1007/S00280-008-0902-8
P577
2009-01-08T00:00:00Z